Personalized care for advanced pancreatic cancer
Part of Cancer clinical trials.
This trial is testing a new way to treat pancreatic cancer that has spread to nearby tissues but not to distant organs. It uses a tailored plan that may include chemotherapy and possibly surgery. The goal is to see if this personalized approach helps people live longer and better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of pancreatic cancer that is borderline resectable or locally advanced, meaning it has grown into nearby areas but hasn't spread to distant organs.
- Your cancer has been confirmed by a biopsy or cell sample as adenocarcinoma.
- You are over 18 years old.
- You are healthy enough to receive chemotherapy and possibly have surgery.
- You agree to participate and sign a consent form.
- If you are a woman able to have children, you must use effective birth control. Pregnant or breastfeeding women cannot join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an “implementation program” to help patients with locally advanced pancreatic cancer get ready for the next steps after chemotherapy. It may help improve care planning and outcomes for people whose cancer has not grown after initial treatment.
This study looks at people with borderline-resectable or locally advanced pancreatic cancer to see how treatment choices affect survival, quality of life, and whether tumors can be removed by surgery. It may help doctors better predict who can benefit from surgical approaches and what outcomes matter most to patients.
This trial tests a combination of targeted radiation and two oral drugs (defactinib and avutometinib) for people with advanced pancreatic cancer that hasn't spread to distant organs. It may be an option if you've already had at least 2 months of chemo and your cancer is still locally advanced or borderline resectable.
This study tests whether tailoring chemotherapy drugs to your tumor's genetic signature helps treat borderline resectable pancreatic cancer (a type that sits between operable and inoperable). You'll receive chemotherapy before surgery, and the combination used will depend on specific markers found in your tumor.
This trial tests a new treatment for people with advanced pancreatic cancer that has spread and is not removable by surgery, after standard treatments like chemotherapy no longer work. The goal is to see if this experimental therapy can help shrink tumors or slow the disease.
This trial studies whether giving chemotherapy before surgery, and possibly adding a focused high-dose radiation treatment, can improve outcomes for people with borderline resectable pancreatic cancer. It aims to shrink or control the cancer and help more patients get to surgery safely.
Hear when a new Locally Advanced Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.